PERILS AND DILEMMAS OF THE INDISCRIMINATE USE OF GLP‑1 AGONISTS FOR AESTHETIC WEIGHT LOSS. REMUNOM 2025, 17 (1), 1-9. https://doi.org/10.61164/4bahhw68.